DÃaz-Troyano, N.; Gabriel-Medina, P.; Weber, S.; Klammer, M.; BarquÃn-DelPino, R.; Castillo-Ribelles, L.; Esteban, A.; Hernández-González, M.; Ferrer-Costa, R.; Pumarola, T.;
et al. Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics 2022, 12, 886.
https://doi.org/10.3390/diagnostics12040886
AMA Style
DÃaz-Troyano N, Gabriel-Medina P, Weber S, Klammer M, BarquÃn-DelPino R, Castillo-Ribelles L, Esteban A, Hernández-González M, Ferrer-Costa R, Pumarola T,
et al. Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics. 2022; 12(4):886.
https://doi.org/10.3390/diagnostics12040886
Chicago/Turabian Style
DÃaz-Troyano, Noelia, Pablo Gabriel-Medina, Stephen Weber, Martin Klammer, Raquel BarquÃn-DelPino, Laura Castillo-Ribelles, Angels Esteban, Manuel Hernández-González, Roser Ferrer-Costa, Tomas Pumarola,
and et al. 2022. "Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2" Diagnostics 12, no. 4: 886.
https://doi.org/10.3390/diagnostics12040886
APA Style
DÃaz-Troyano, N., Gabriel-Medina, P., Weber, S., Klammer, M., BarquÃn-DelPino, R., Castillo-Ribelles, L., Esteban, A., Hernández-González, M., Ferrer-Costa, R., Pumarola, T., & RodrÃguez-FrÃas, F.
(2022). Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2. Diagnostics, 12(4), 886.
https://doi.org/10.3390/diagnostics12040886